Delivery Order SPE2DB20D2014-SPE2DB25FB16J

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,671.34, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of February 25, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.65, is a firm fixed-price delivery order for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,438.57, is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of November 22, 2023 and is a Firm Fixed Price Delivery Order. There is no set-aside designation indicated for this award. AmerisourceBergen also holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,780.63, is a Delivery Order for the provision of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 12, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,741.20 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $7,028.80 with a completion date of January 31, 2025. The award, from the Defense Logistics Agency (DLA), is for the provision of 4567102555 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,826.44, is a delivery order for the TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medical product. The award has an ultimate completion date of January 3, 2025 and is a firm-fixed-price contract. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,618.07, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,404.60, is a delivery order for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of November 25, 2024 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,838.05 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB16J
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,861.34, is a delivery order for the product "TRULICITY 0.75 MG/0.5 ML PEN 0.5ML". The contract is a firm fixed-price agreement with a completion date of February 25, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award was not designated with a set-aside requirement, indicating open competition.

Generated 6/1/25, 2:48 AM